AKTX vs CYTK
Akari Therapeutics, Plc · Cytokinetics, Incorporated
Relative return (rebased to 100)
Key stats
| Metric | AKTX | CYTK |
|---|---|---|
| Price | $7.90 | $76.10 |
| Market Cap | $723.29B | $9.47B |
| P/E | — | — |
| P/B | 50298.18 | — |
| P/S | 1966113.15 | 107.56 |
| ROE | -120.3% | — |
| Net Margin | -4702.1% | -891.6% |
| Gross Margin | — | — |
| Revenue Growth | -39.5% | 376.6% |
| Dividend Yield | — | — |
| EPS | -$0.00 | -$6.31 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.